Clinical Trials Logo

Psoriasis of Scalp clinical trials

View clinical trials related to Psoriasis of Scalp.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05938361 Recruiting - Psoriasis of Scalp Clinical Trials

Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis

ZODIPSO
Start date: June 1, 2023
Phase:
Study type: Observational

Psoriasis is a chronic inflammatory disease that affects between 2% and 4% of the French population.Some specific localizations are more difficult to manage, such as the scalp, nails, genital region and palmoplantar localizations. Tildrakizumab, an anti-interleukin-23 (IL-23) monoclonal antibody, has demonstrated efficacy and safety in the treatment of patients with moderate to severe psoriasis. Real-life data on the efficacy of Tildrakizumab in unselected patients with these difficult-to-treat locations are still limited. The aim of the ZODIPSO study is to evaluate the efficacy and safety of Tildrakizumab in patients presented difficult to treat locations in psoriasis : nail, scalp, genital and palmoplantar. The main objective is to assess the overall response and the specific response to Tildrakizumab at these specific areas up to W52.

NCT ID: NCT05858632 Recruiting - Psoriasis of Scalp Clinical Trials

Immune Spatial Features of Guselkumab Cutaneous Response

Start date: July 1, 2023
Phase: Phase 4
Study type: Interventional

This study examines the effect of IL-23 blockade with Guselkumab on the immune cells of scalp psoriasis lesions.

NCT ID: NCT05144165 Recruiting - Psoriasis Clinical Trials

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Start date: November 8, 2021
Phase:
Study type: Observational

French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults have been developed by the psoriasis research group of the French Society of Dermatology using literature available until July 2017 (Amatore et al, 2019). Because several systemic treatments have been marketed since then, new guidelines are mandatory. The aim of this study coordinated by the Centre of Evidence of the French Society of Dermatology is to update the available French guidelines using a Delphi method.

NCT ID: NCT04099979 Recruiting - Psoriasis Clinical Trials

A Pilot Study to Explore the Role of Gut Flora in Psoriasis

Start date: March 2, 2020
Phase:
Study type: Observational

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.